GOSS - BofAML likes HCA in premarket analyst action December, 06 2019 08:12 AM Gossamer Bio Inc. Amedisys (NASDAQ:AMED) initiated with Market Perform rating and $170 (3% upside) price target at BMO.More news on: Amedisys, Inc., Athenex, Inc., Gossamer Bio, Inc., Healthcare stocks news, Stocks on the move, , Read more ...